Pulmonary function studies were carried out in a group of asymptomatic nonsmoking adults with intermediate alpha-1-antitrypsin deficiency who were attending an early disease detection unit in Rochester, N. Y. All subjects were identified by specific protease inhibitor (Pi) typing. Fifteen MZ and 14 MS subjects who had never smoked cigarettes were matched by sex and age to MM controls. Spirometry, static lung volumes, and single breath-diffusing capacity were identical in all Pi type groups with no statistically significant differences noted. Maximal expiratory flow volume curves were obtained in all subjects. MZ subjects demonstrated statistically impaired maximal flow rates at 75%, 50%, and 25% of vital capacity compared to their MM controls. Total pulmonary resistance by the oscillometric method was measured at 3, 5, 7, and 9 cycle/s in the same subjects. Increased frequency dependence of resistance (defined as the difference between total pulmonary resistance at 3 cycle/s and 9 cycle/s) was observed in MZ subjects compared to MM controls. No differences were noted by this method in MS-MM pairs. The data suggest that detectable mechanical abnormalities are present in subjects with the MZ phenotype, even in the absence of established risk factors such as cigarette smoking and high air pollution.
W J Hall, R W Hyde, R H Schwartz, G S Mudholkar, D R Webb, Y P Chaubey, P L Townes
Title and authors | Publication | Year |
---|---|---|
COPD in individuals with the PiMZ alpha-1 antitrypsin genotype
HS Ashry, C Strange |
European Respiratory Review | 2017 |
Maximal mid-expiratory flow detects early lung disease in α 1 -antitrypsin deficiency
JA Stockley, AM Ismail, SM Hughes, R Edgar, RA Stockley, E Sapey |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2017 |
Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications
L Zuo, BK Pannell, T Zhou, CC Chuang |
Gene | 2016 |
Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis
CP Hersh, M Dahl, NP Ly, CS Berkey, BG Nordestgaard, EK Silverman |
Thorax | 2004 |
Influence of deficient α1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults
M Miravitlles, S Vilà, M Torrella, E Balcells, F Rodríguez-Frías, CL Roza, R Jardí, R Vidal |
Respiratory Medicine | 2002 |
Genetic Risk Factors for Chronic Obstructive Pulmonary Disease
AJ Sandford, PD Paré |
Clinics in Chest Medicine | 2000 |
Z and S Mutations of the α 1 -Antitrypsin Gene and the Risk of Chronic Obstructive Pulmonary Disease
AJ Sandford, TD Weir, JJ Spinelli, PD Paré |
American journal of respiratory cell and molecular biology | 1999 |
Natural history of alpha-1-protease inhibitor deficiency
DC Hutchison |
The American Journal of Medicine | 1988 |
Southwestern Internal Medicine Conference: Pulmonary Emphysema: Current Concepts of Pathogenesis
JC Weissler |
The American Journal of the Medical Sciences | 1987 |
Lung function in an Australian population: contributions of polygenic factors and the Pi locus to individual differences in lung function in a sample of twins
JB Gibson, NG Martin, JG Oakeshott, DM Rowell, P Clark |
Annals of Human Biology | 1983 |
Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects
JE Gadek, HG Klein, PV Holland, RG Crystal |
Journal of Clinical Investigation | 1981 |
Danazol-induced Augmentation of Serum α1-Antitrypsin Levels in Individuals with Marked Deficiency of this Antiprotease
JE Gadek, JD Fulmer, JA Gelfand, MM Frank, TL Petty, RG Crystal |
Journal of Clinical Investigation | 1980 |
Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population
DJ McDonagh, SP Nathan, RJ Knudson, MD Lebowitz |
Journal of Clinical Investigation | 1979 |
Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ)
SF Tattersall, RP Pereira, D Hunter, G Blundell, NB Pride |
Thorax | 1979 |